Intervention

THR-687 dose level 2

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions3

Lead sponsors shown2

Clinical trials

2 shown

A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema.NCT05063734 · 2021-08-27

A Study to Evaluate the Safety of THR-687 in Subjects With Diabetic Macular Edema (DME)NCT03666923 · 2018-09-17

Common conditions

Diabetes Mellitus2 Diabetic Macular Edema2 Diabetic Retinopathy2

Leading sponsors

Oxurion1 ThromboGenics1

Trial status mix

COMPLETED1

TERMINATED1

Phase mix

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.